The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5470
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis ; day:10 ; month:3 ; year:2018 ; pages:1-5
Genes and immunity ; (10.3.2018), 1-5
- Creator
-
Watts, Laura
- Contributor
-
Karaderi, Tugce
Roberts, Amity
Appleton, Louise
Wordsworth, Tom
Cohen, Carla
Wordsworth, Paul
Vecellio, Matteo
SpringerLink (Online service)
- DOI
-
10.1038/s41435-018-0017-0
- URN
-
urn:nbn:de:1111-2018051617003
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Watts, Laura
- Karaderi, Tugce
- Roberts, Amity
- Appleton, Louise
- Wordsworth, Tom
- Cohen, Carla
- Wordsworth, Paul
- Vecellio, Matteo
- SpringerLink (Online service)
Other Objects (12)
Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
Production of tumour necrosis factor during murine cutaneous leishmaniasis
Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
Natural Inhibitors of Tumour Necrosis Factor-α Production, Secretion and Function
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
Production of tumour necrosis factor during murine cutaneous leishmaniasis
Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
Natural Inhibitors of Tumour Necrosis Factor-α Production, Secretion and Function
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
Production of tumour necrosis factor during murine cutaneous leishmaniasis
Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
Exogenous tumour necrosis factor α induces suppression of autoimmune arthritis
Commercially Available Antibodies to Human Tumour Necrosis Factor-α Tested for Cross-Reactivity with Ovine and Bovine Tumour Necrosis Factor-α using Flow Cytometric Assays
Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
Natural Inhibitors of Tumour Necrosis Factor-α Production, Secretion and Function
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases